Adapted Argentine tango dance therapy is helping some breast cancer survivors regain natural balance and sensation after experiencing neuropathy, a common side effect of chemotherapy treatment. Expansion of a new clinical study will look further at how this musical movement intervention can “rewire” the brain to improve function after chemotherapy-related nerve changes.
The OSUCCC – James announces the following awards, honors, grants and more that were recently given to the organization, teams or individuals.
Pelotonia 2025 registration is now open. This year’s Pelotonia events will include Opening Ceremony on August 1, Ride Weekend on August 2 and 3 and Gravel Day on October 4. Participants can register as Riders, Volunteers or Challengers, plus new this year, Gravel Day Runners and Hikers, at pelotonia.org/register.
While HPV is most associated with cervical cancer risk and women, a new survey commissioned by the OSUCCC – James shows that the majority of people are unaware that the virus is actually more common among men than women and is associated with rising rates of other cancers that directly impact men.
The OSUCCC – James announces the following awards, honors, grants and more that were recently given to the organization, teams or individuals.
The OSUCCC – James announces the following awards, honors, grants and more that were recently given to the organization, teams or individuals.
Jennifer Woyach, MD, a world-renowned blood cancer doctor and researcher who has been with Ohio State for more than 12 years, has been named director of the Division of Hematology at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.
The OSUCCC – James announces awards, honors, grants and more that were recently given to the organization, teams or individuals in December 2024.
The OSUCCC – James announces today it will form a new partnership with Zangmeister Cancer Center, a partner practice of American Oncology Network. This collaboration will expand access to medical oncology and hematology care for patients in central Ohio and provide broader range of options, including both academic and community-based sites of care.
Recently, a team at the OSUCCC – James completed its first gene therapy for a patient with hemophilia B, the first at an adult medical center in Ohio.